$1.91
▲ +0.3% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ...
Lantern Pharma Inc. Q2 2026 Earnings Call Summary
Overview
52-week range
$1.11
$4.70
22% of range
Avg surprise (last 1)
+24.5%
Avg reaction (last 2)
-2.3%
50% positive
Latest IV / EM
1106%
EM ±122.2% · $4 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.57 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.30 | — | — | +28.6% | +0.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.39 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.40 | $-0.53 | +24.5% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.42 | — | — | — | -4.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.42 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.46 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.51 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.29 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.44 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.36 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-3M | — | $-4M | $-5M | $-5M | — | $-5M |
| Net income | $-7M | $-3M | — | $-4M | $-4M | $-5M | — | $-5M |
| EPS (diluted) | $-0.57 | $-0.30 | — | $-0.39 | $-0.40 | $-0.42 | — | $-0.42 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $5M | $4M | $8M | $6M | $6M | $8M | $8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $8M | $7M | $11M | $13M | $17M | $21M | $25M | $30M |
| Total assets | $9M | $7M | $11M | $14M | $17M | $21M | $26M | $30M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $12M | $4M | $5M | $4M | $5M | $4M | $4M | $4M |
| Total equity | $-3M | $3M | $7M | $10M | $13M | $17M | $21M | $27M |